栄養補助食品成分市場：タイプ、形態、供給源、健康効果、用途、流通チャネル、エンドユーザー別-2025-2030年世界予測

栄養補助食品成分市場は、2024年には2,278億1,000万米ドルとなり、2025年にはCAGR 8.83%で2,481億米ドルに成長し、2030年には3,785億5,000万米ドルに達すると予測されています。

栄養補助食品原料市場は、消費者意識の高まり、技術革新、ライフスタイル動向の進化に牽引され、過去10年間で空前の成長を遂げました。科学と自然が融合するこの業界において、企業は研究ベースのアプローチを採用し、健康、ウェルネス、予防医療に対応する成分を開発しています。消費者の健康嗜好の急速な進化とウェルネスへの世界のシフトは、栄養補助食品イノベーションの肥沃な土壌を作り出しました。本レポートでは、市場を再構築した変革的動向の概略、詳細なセグメンテーション考察、地域別・競合分析により、利害関係者に業界の現状と将来の軌道を360度見渡すことができます。

バイオテクノロジー、製剤科学、規制監督における進歩は、持続可能な成長のためのロードマップを作成するために収束しつつあります。メーカーやサプライヤーがこのダイナミックな分野を乗り切るには、調査、消費者の要望、科学的イノベーションの相互作用を理解することが不可欠となります。この包括的なレビューでは、過去の動向を探るだけでなく、将来の成長の道筋を予測し、意思決定者が実用的な洞察の信頼できる情報源を得られるようにしています。そうすることで、本レポートは、健康上の成果を高める上で栄養補助食品成分が果たす重要な役割と、世界の健康と栄養の未来を形作る可能性を浮き彫りにしています。

以下のセクションでは、変革的な市場シフト、きめ細かなセグメンテーション考察、地域別の展望、競合分析を詳しく解説しています。本レポートの各セクションでは、課題とユニークな機会の両方をもたらす特定の要因を明らかにし、戦略的提言と結論・洞察によって将来の成長イニシアティブへの道を開いています。

栄養補助食品原料の情勢における変革的変化

近年、ニュートラシューティカルズ関連原料市場は、いくつかの影響力のある要因によって変貌を遂げています。世界の消費者行動は現在、予防的な健康戦略や個別化された栄養への傾倒を強めており、的を絞った科学的裏付けのある効能を提供する成分への需要を牽引しています。製剤設計と抽出技術の革新は、多様な健康課題に対応する、より強力で生物学的利用能の高い多機能成分への道を開いた。研究主導の考察は、新成分の開発と製造プロセスの改良において企業を導き、業界を競合と先進の両方へと導いています。

技術の進歩と栄養科学への深い理解も、この変革の重要な触媒となっています。開発メーカーは現在、生化学や分子栄養学における画期的な進歩を活用して、心臓の健康や認知機能といった一般的な健康問題に対応するだけでなく、個別化栄養計画のような新たな動向もサポートする成分を開発しています。このような技術革新は、臨床効果と消費者の信頼が一体となった環境を育む研究開発への堅実な投資によって補完されています。

さまざまな地域の規制改革は、品質と安全性に関するより高い基準を設定することによって、こうしたシフトをさらに促進し、栄養補助食品に対する消費者の信頼を高めています。規制の調和により、市場への参入がよりスムーズになり、国境を越えた取引が促進され、国際的な協力関係が活性化しています。その結果、企業は継続的な進化を余儀なくされ、斬新で持続可能な、倫理的に調達された成分を含むよう、成分ポートフォリオを見直す必要に迫られています。こうした市場の力が相互に作用することで、業務が合理化されるだけでなく、製品性能の卓越性を追求する競争にも拍車がかかり、最終的に業界内に新たな成長路線が生み出されています。

栄養補助食品市場の主要セグメンテーション洞察

栄養補助食品原料市場を詳細に分析すると、いくつかの主要なセグメンテーションの次元にわたって深い洞察が明らかになります。例えば、成分の種類を考慮する場合、市場はアミノ酸、繊維、ハーブエキス、ミネラル、プロバイオティクス、ビタミンなどのカテゴリーにわたって綿密に調査されます。各カテゴリーはさらに細分化され、アミノ酸は必須と非必須、繊維は不溶性と水溶性、ハーブエキスはエキナセア、高麗人参、緑茶など、ミネラルはカルシウム、鉄、マグネシウム、亜鉛など、プロバイオティクスはビフィズス菌、乳酸菌、連鎖球菌、酵母ベースの製剤などの菌株に基づいて評価され、ビタミンはビタミンA、B、C、Dを詳細に調査しています。この微妙なアプローチにより、各成分の本質的な特性と性能の可能性をより深く理解することができます。

さらに、製品はカプセル、液体、粉末、錠剤など様々な形態で提供され、それぞれの形態で製造上の課題や消費者への訴求力が異なります。成分の供給源も重要な役割を果たしており、研究では動物由来、植物由来、合成由来を区別しています。注目すべきは、動物由来はさらにウシ由来と乳清由来に分けられ、植物由来はエンドウ豆、コメ、大豆などの選択肢で評価されていることです。この差別化は、原料調達におけるトレーサビリティと持続可能性の重要性を強調しています。

セグメンテーションのもう一つの層は健康上の利点に焦点を当て、骨と関節の健康、認知能力、消化器系の健康、心臓の健康（特に血圧調整とコレステロール管理に重点を置く）、効果的な体重管理への影響に従って製品を分類します。また、栄養補助食品、機能性飲食品、機能性食品、パーソナルケア製品における成分の有用性を判断するため、用途も詳細に分類しています。さらなるセグメンテーションでは、オフラインとオンラインの市場動向を比較する流通チャネルや、成人、高齢者、小児にまたがるエンドユーザーの属性を調査します。この多角的なセグメンテーションの枠組みにより、業界の利害関係者は、消費者のニーズと市場力学に合わせた具体的な機会を確実に特定することができます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 栄養補助食品成分市場の成長を加速させる根本的な力を探る
    • セクター全体で栄養補助食品成分の台頭に重要な役割を果たしている重要な側面
    • 栄養補助食品業界の拡大の波を後押しする主な要因についての洞察
  • 抑制要因
    • 栄養補助食品成分市場動態を左右する抑止力を徹底検証
    • 成長を阻害する課題の包括的な分析栄養補助食品成分市場
    • 栄養補助食品成分市場の進化に立ち向かう極めて重要なハードルを特定する
  • 機会
    • 高齢者層がターゲットを絞った健康効果を求める中、高齢者向け栄養補助食品にチャンスあり
    • パーソナライズされた栄養の人気の高まりにより、カスタマイズされた栄養補助食品の需要が高まっています。
    • 消費者が持続可能なライフスタイルに移行するにつれて、植物由来の栄養補助食品の需要が高まっています
  • 課題
    • 生産コストと収益性に影響を与える原材料不足と価格変動の管理
    • 複雑な栄養補助食品原料のサプライチェーン全体で一貫した品質とトレーサビリティを確保
    • 成分の有効性と安全性に関するさまざまな、そしてしばしば矛盾する調査結果に取り組む
• 市場セグメンテーション分析
  • 形態：保存期間が長いため乾燥形態の需要がある栄養補助食品成分
  • 応用：パーソナライズされた栄養の開発のための栄養補助食品全体での活用
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 栄養補助食品成分市場：タイプ別

• アミノ酸
  • 不可欠
  • 不要
• 繊維
  • 不溶性
  • 可溶性
• ハーブエキス
  • エキナセア
  • 人参
  • 緑茶
• ミネラル
  • カルシウム
  • 鉄
  • マグネシウム
  • 亜鉛
• プロバイオティクス
  • ビフィズス菌
  • 乳酸菌
  • 連鎖球菌
  • 酵母ベース
• ビタミン
  • ビタミンA
  • ビタミンB
  • ビタミンC
  • ビタミンD

第7章 栄養補助食品成分市場：形態別

• カプセル
• 液体
• 粉
• 錠剤

第8章 栄養補助食品成分市場：ソース別

• 動物由来
  • 牛
  • 乳清
• 植物由来
  • エンドウ
  • 米
  • 大豆
• 合成

第9章 栄養補助食品成分市場健康上の利点

• 骨と関節の健康
• 認知健康
• 消化器系の健康
• 心臓の健康
  • 血圧調節
  • コレステロール管理
• 体重管理

第10章 栄養補助食品成分市場：用途別

• 栄養補助食品
• 機能性飲料
• 機能性食品
• パーソナルケア

第11章 栄養補助食品成分市場：流通チャネル別

• オフライン
• オンライン

第12章 栄養補助食品成分市場：エンドユーザー別

• 大人
• 高齢者
• 小児科

第13章 南北アメリカの栄養補助食品成分市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第14章 アジア太平洋地域の栄養補助食品成分市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第15章 欧州・中東・アフリカの栄養補助食品成分市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第16章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Ajinomoto Co., Inc.
• Amway Corporation
• Archer-Daniels-Midland Company
• Arla Foods amba
• Balchem Corporation
• BASF SE
• Bioriginal Food & Science Corp
• Cargill, Incorporated
• Danone S.A.
• DuPont de Nemours, Inc.
• Fonterra Co-operative Group Limited
• Givaudan
• Glanbia PLC
• Indena S.p.A.
• Ingredion Incorporated
• Kemin Industries, Inc.
• Kerry Group PLC
• Koninklijke DSM N.V.
• Lonza Group
• Nestle S.A.
• Nexira SAS
• Parchem Fine & Specialty Chemicals, Inc.
• Pfizer Inc.
• Prinova Group LLC
• Roquette Freres
• Sabinsa Corporation
• Seppic S.A.
• Tate & Lyle PLC

LIST OF FIGURES

• FIGURE 1. NUTRACEUTICAL INGREDIENTS MARKET MULTI-CURRENCY
• FIGURE 2. NUTRACEUTICAL INGREDIENTS MARKET MULTI-LANGUAGE
• FIGURE 3. NUTRACEUTICAL INGREDIENTS MARKET RESEARCH PROCESS
• FIGURE 4. NUTRACEUTICAL INGREDIENTS MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
• FIGURE 19. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
• FIGURE 21. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 25. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 27. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 28. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 29. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 30. NUTRACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 31. NUTRACEUTICAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. NUTRACEUTICAL INGREDIENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NUTRACEUTICAL INGREDIENTS MARKET DYNAMICS
• TABLE 7. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ESSENTIAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY NON-ESSENTIAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY INSOLUBLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOLUBLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ECHINACEA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY GINSENG, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY GREEN TEA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY CALCIUM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY IRON, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MAGNESIUM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ZINC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERAL, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY BIFIDOBACTERIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY LACTOBACILLI, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY STREPTOCOCCUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY YEAST-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN A, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN B, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN C, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN D, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY WHEY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PLANT-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PEA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 51. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY RICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 52. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 53. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 54. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 55. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
• TABLE 56. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY BONE & JOINT HEALTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 57. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 58. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DIGESTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 59. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 60. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY BLOOD PRESSURE REGULATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 61. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY CHOLESTEROL MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 62. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, 2018-2030 (USD MILLION)
• TABLE 63. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY WEIGHT MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 64. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 66. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FUNCTIONAL BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 67. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FUNCTIONAL FOOD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 68. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 69. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 70. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 71. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 72. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 74. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 75. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 76. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
• TABLE 78. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS, 2018-2030 (USD MILLION)
• TABLE 79. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
• TABLE 80. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERAL, 2018-2030 (USD MILLION)
• TABLE 81. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 82. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN, 2018-2030 (USD MILLION)
• TABLE 83. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 84. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 85. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
• TABLE 86. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 87. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
• TABLE 88. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, 2018-2030 (USD MILLION)
• TABLE 89. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 91. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 93. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
• TABLE 95. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS, 2018-2030 (USD MILLION)
• TABLE 96. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
• TABLE 97. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERAL, 2018-2030 (USD MILLION)
• TABLE 98. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 99. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN, 2018-2030 (USD MILLION)
• TABLE 100. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 101. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 102. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
• TABLE 103. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 104. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
• TABLE 105. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, 2018-2030 (USD MILLION)
• TABLE 106. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 108. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
• TABLE 111. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS, 2018-2030 (USD MILLION)
• TABLE 112. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
• TABLE 113. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERAL, 2018-2030 (USD MILLION)
• TABLE 114. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 115. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN, 2018-2030 (USD MILLION)
• TABLE 116. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 117. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 118. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
• TABLE 119. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 120. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
• TABLE 121. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, 2018-2030 (USD MILLION)
• TABLE 122. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 124. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
• TABLE 127. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS, 2018-2030 (USD MILLION)
• TABLE 128. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
• TABLE 129. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERAL, 2018-2030 (USD MILLION)
• TABLE 130. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 131. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN, 2018-2030 (USD MILLION)
• TABLE 132. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 133. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 134. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
• TABLE 135. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 136. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
• TABLE 137. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, 2018-2030 (USD MILLION)
• TABLE 138. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 140. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
• TABLE 143. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS, 2018-2030 (USD MILLION)
• TABLE 144. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
• TABLE 145. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERAL, 2018-2030 (USD MILLION)
• TABLE 146. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 147. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN, 2018-2030 (USD MILLION)
• TABLE 148. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 149. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 150. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
• TABLE 151. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 152. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
• TABLE 153. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, 2018-2030 (USD MILLION)
• TABLE 154. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 156. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 158. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
• TABLE 159. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS, 2018-2030 (USD MILLION)
• TABLE 160. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
• TABLE 161. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERAL, 2018-2030 (USD MILLION)
• TABLE 162. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 163. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN, 2018-2030 (USD MILLION)
• TABLE 164. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 165. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 166. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
• TABLE 167. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 168. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
• TABLE 169. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, 2018-2030 (USD MILLION)
• TABLE 170. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 172. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 173. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 174. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
• TABLE 176. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS, 2018-2030 (USD MILLION)
• TABLE 177. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
• TABLE 178. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERAL, 2018-2030 (USD MILLION)
• TABLE 179. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 180. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN, 2018-2030 (USD MILLION)
• TABLE 181. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 182. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 183. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
• TABLE 184. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 185. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
• TABLE 186. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, 2018-2030 (USD MILLION)
• TABLE 187. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 189. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 190. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 191. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 192. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
• TABLE 193. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS, 2018-2030 (USD MILLION)
• TABLE 194. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
• TABLE 195. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERAL, 2018-2030 (USD MILLION)
• TABLE 196. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 197. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN, 2018-2030 (USD MILLION)
• TABLE 198. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 199. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 200. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
• TABLE 201. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 202. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
• TABLE 203. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, 2018-2030 (USD MILLION)
• TABLE 204. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 206. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 207. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 208. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
• TABLE 209. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS, 2018-2030 (USD MILLION)
• TABLE 210. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
• TABLE 211. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERAL, 2018-2030 (USD MILLION)
• TABLE 212. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 213. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN, 2018-2030 (USD MILLION)
• TABLE 214. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 215. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 216. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
• TABLE 217. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 218. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
• TABLE 219. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, 2018-2030 (USD MILLION)
• TABLE 220. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 221. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 222. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 223. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 224. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
• TABLE 225. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS, 2018-2030 (USD MILLION)
• TABLE 226. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
• TABLE 227. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERAL, 2018-2030 (USD MILLION)
• TABLE 228. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 229. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN, 2018-2030 (USD MILLION)
• TABLE 230. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 231. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 232. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
• TABLE 233. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 234. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
• TABLE 235. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, 2018-2030 (USD MILLION)
• TABLE 236. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 238. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 239. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 240. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
• TABLE 241. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS, 2018-2030 (USD MILLION)
• TABLE 242. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
• TABLE 243. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERAL, 2018-2030 (USD MILLION)
• TABLE 244. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 245. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN, 2018-2030 (USD MILLION)
• TABLE 246. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 247. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 248. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
• TABLE 249. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 250. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
• TABLE 251. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, 2018-2030 (USD MILLION)
• TABLE 252. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 253. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 254. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 255. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 256. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
• TABLE 257. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS, 2018-2030 (USD MILLION)
• TABLE 258. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
• TABLE 259. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERAL, 2018-2030 (USD MILLION)
• TABLE 260. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 261. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN, 2018-2030 (USD MILLION)
• TABLE 262. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 263. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 264. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
• TABLE 265. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 266. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
• TABLE 267. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, 2018-2030 (USD MILLION)
• TABLE 268. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 269. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 270. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 271. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 272. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
• TABLE 273. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS, 2018-2030 (USD MILLION)
• TABLE 274. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
• TABLE 275. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERAL, 2018-2030 (USD MILLION)
• TABLE 276. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 277. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN, 2018-2030 (USD MILLION)
• TABLE 278. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 279. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 280. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
• TABLE 281. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 282. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
• TABLE 283. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, 2018-2030 (USD MILLION)
• TABLE 284. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 285. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 286. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 287. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 288. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
• TABLE 289. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS, 2018-2030 (USD MILLION)
• TABLE 290. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
• TABLE 291. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERAL, 2018-2030 (USD MILLION)
• TABLE 292. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 293. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN, 2018-2030 (USD MILLION)
• TABLE 294. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 295. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 296. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
• TABLE 297. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 298. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
• TABLE 299. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, 2018-2030 (USD MILLION)
• TABLE 300. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 301. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 302. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 303. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 304. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
• TABLE 305. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS, 2018-2030 (USD MILLION)
• TABLE 306. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
• TABLE 307. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERAL, 2018-2030 (USD MILLION)
• TABLE 308. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 309. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN, 2018-2030 (USD MILLION)
• TABLE 310. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 311. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 312. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
• TABLE 313. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 314. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
• TABLE 315. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, 2018-2030 (USD MILLION)
• TABLE 316. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 317. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 318. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 319. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 320. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
• TABLE 321. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS, 2018-2030 (USD MILLION)
• TABLE 322. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
• TABLE 323. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERAL, 2018-2030 (USD MILLION)
• TABLE 324. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 325. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMIN, 2018-2030 (USD MILLION)
• TABLE 326. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 327. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 328. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
• TABLE 329. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 330. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
• TABLE 331. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, 2018-2030 (USD MILLION)
• TABLE 332. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION

The Nutraceutical Ingredients Market was valued at USD 227.81 billion in 2024 and is projected to grow to USD 248.10 billion in 2025, with a CAGR of 8.83%, reaching USD 378.55 billion by 2030.

The nutraceutical ingredients market has experienced unprecedented growth over the past decade, driven by heightened consumer awareness, technological innovation, and evolving lifestyle trends. In an industry where science meets nature, companies are embracing research-based approaches to develop ingredients that cater to health, wellness, and preventive care. The rapid evolution in consumer health preferences and a global shift toward wellness have created a fertile ground for nutraceutical innovation. This report outlines the transformative trends that have reshaped the market, discusses detailed segmentation insights, and provides a regional and competitive analysis that offers stakeholders a 360-degree view of the industry's current landscape and future trajectory.

Advancements in biotechnology, formulation sciences, and regulatory oversight are converging to create a roadmap for sustainable growth. As manufacturers and suppliers navigate this dynamic field, understanding the interplay between research, consumer demands, and scientific innovation becomes essential. This comprehensive review not only explores historical trends but also projects future growth avenues, ensuring that decision-makers have a reliable source of actionable insights. In doing so, the report highlights the critical role of nutraceutical ingredients in enhancing health outcomes and their potential to shape the future of global health and nutrition.

The following sections provide a detailed exploration of transformative market shifts, granular segmentation insights, regional perspectives, and competitive analysis. Each segment of the report unveils specific factors that present both challenges and unique opportunities, augmented by strategic recommendations and conclusive insights that pave the way for future growth initiatives.

Transformative Shifts in the Landscape of Nutraceutical Ingredients

In recent years, the nutraceutical ingredients market has undergone transformative shifts driven by several influential factors. Global consumer behavior is now more inclined towards preventive health strategies and personalized nutrition, driving the demand for ingredients that offer targeted, scientifically-backed benefits. Innovations in formulation design and extraction technologies have paved the way for more potent, bioavailable, and multifunctional ingredients that cater to diverse health challenges. Research-driven insights are guiding companies in developing new ingredients and refining production processes, making the industry both competitive and forward-thinking.

Technological advancements and a deeper understanding of nutritional science have also been key catalysts in this transformation. Manufacturers are now leveraging breakthroughs in biochemistry and molecular nutrition to develop ingredients that not only address common health issues such as heart health and cognitive function but also support emerging trends like personalized nutrition regimens. Such innovation is complemented by robust investments in research and development which foster an environment where clinical efficacy and consumer trust coalesce.

Regulatory reforms across various regions have further catalyzed these shifts by setting higher standards for quality and safety, thereby increasing consumer confidence in nutraceutical products. Harmonized regulations are facilitating smoother market entry, encouraging cross-border trade, and stimulating international collaboration. As a result, companies are compelled to evolve continuously, revising their ingredient portfolios to include novel, sustainable, and ethically-sourced components. The interplay of these market forces has not only streamlined operations but has also spurred a competitive push toward excellence in product performance, ultimately creating new growth avenues within the industry.

Key Segmentation Insights in the Nutraceutical Market

An in-depth analysis of the nutraceutical ingredients market reveals profound insights across several key segmentation dimensions. For instance, when considering the ingredient type, the market is meticulously studied across categories including amino acids, fibers, herbal extracts, minerals, probiotics, and vitamins. Each category is further subdivided: amino acids are classified as essential and non-essential, fibers are delineated as insoluble and soluble, herbal extracts include varieties such as Echinacea, Ginseng, and Green Tea, minerals are identified by elements such as calcium, iron, magnesium, and zinc, probiotics are evaluated based on strains like Bifidobacteria, Lactobacilli, Streptococcus, and yeast-based formulations, while vitamins are examined in detail covering Vitamin A, B, C, and D. This nuanced approach enables a deeper understanding of the intrinsic properties and performance potentials of each ingredient.

Furthermore, the market is analyzed from a formulation perspective, where products are offered in various forms including capsules, liquids, powders, and tablets, each format presenting unique manufacturing challenges and consumer appeal. The source of ingredients also plays a critical role, with studies distinguishing between animal-based, plant-based, and synthetic origins. Notably, animal-based derivations further divide into bovine and whey, while plant-based ingredients are evaluated across options such as pea, rice, and soy. This differentiation underlines the importance of traceability and sustainability in ingredient sourcing.

Another layer of segmentation focuses on health benefits, categorizing products according to their impact on bone and joint health, cognitive performance, digestive health, heart health-with special focus on blood pressure regulation and cholesterol management-and effective weight management. Applications also undergo a detailed breakdown, determining the utility of ingredients in dietary supplements, functional beverages, functional food, and personal care products. Additional segmentation examines distribution channels, comparing offline with online market trends, as well as end-user demographics spanning adults, geriatric populations, and pediatrics. This multidimensional segmentation framework ensures that industry stakeholders can pinpoint specific opportunities tailored to precise consumer needs and market dynamics.

Based on Type, market is studied across Amino Acids, Fibers, Herbal Extracts, Mineral, Probiotics, and Vitamin. The Amino Acids is further studied across Essential and Non-essential. The Fibers is further studied across Insoluble and Soluble. The Herbal Extracts is further studied across Echinacea, Ginseng, and Green Tea. The Mineral is further studied across Calcium, Iron, Magnesium, and Zinc. The Probiotics is further studied across Bifidobacteria, Lactobacilli, Streptococcus, and Yeast-Based. The Vitamin is further studied across Vitamin A, Vitamin B, Vitamin C, and Vitamin D.

Based on Form, market is studied across Capsule, Liquid, Powder, and Tablet.

Based on Source, market is studied across Animal-Based, Plant-Based, and Synthetic. The Animal-Based is further studied across Bovine and Whey. The Plant-Based is further studied across Pea, Rice, and Soy.

Based on Health Benefits, market is studied across Bone & Joint Health, Cognitive Health, Digestive Health, Heart Health, and Weight Management. The Heart Health is further studied across Blood Pressure Regulation and Cholesterol Management.

Based on Application, market is studied across Dietary Supplements, Functional Beverages, Functional Food, and Personal Care.

Based on Distribution Channel, market is studied across Offline and Online.

Based on End User, market is studied across Adults, Geriatric, and Pediatric.

Key Regional Insights Shaping Market Dynamics

Regional developments play a pivotal role in framing the overall market dynamics. In the Americas, a confluence of innovation, favorable regulatory policies, and a robust consumer market has propelled nutraceutical ingredients into mainstream wellness strategies, encouraging both local and multinational companies to invest heavily in research and development. The region's booming interest in preventative healthcare continues to drive product diversification, consequently influencing market growth.

Across Europe, the Middle East, and Africa, a strong emphasis is placed on quality and safety can be observed. Stringent regulatory frameworks ensure that ingredients meet high standards, thereby reinforcing consumer trust. Emerging trends within these regions include a growing consumer base that is increasingly aware of the health benefits associated with nutraceutical products, prompting further investment in sustainable sourcing and cutting-edge technologies. These regions also demonstrate a marked shift towards integrating traditional wellness practices with modern nutritional science, a trend that further diversifies the industry landscape.

In the Asia-Pacific region, rapid urbanization coupled with rising disposable incomes is fostering a surge in demand for innovative nutraceutical ingredients. The region has witnessed significant investment in research initiatives that incorporate traditional herbal knowledge with modern science, driving the evolution of ingredient profiles. Across all regions, consistent trends in consumer health awareness and technological adoption are evident, underscoring the global nature of the market's growth trajectory and the importance of regional strategies in tapping into emerging opportunities.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights from Leading Global Players

An examination of the competitive landscape reveals the presence of several influential global leaders who are driving innovation in the nutraceutical ingredients market. Companies such as Ajinomoto Co., Inc. and Amway Corporation have continued to push boundaries with their extensive research capabilities and expansive product portfolios. Other key players including Archer-Daniels-Midland Company and Arla Foods amba have leveraged strategic partnerships to enhance their market footprints, while Balchem Corporation and BASF SE have been at the forefront of developing advanced formulations.

Market leaders such as Bioriginal Food & Science Corp and Cargill, Incorporated have combined technological innovation with deep market insights to capture niche segments. Danone S.A. and DuPont de Nemours, Inc. are notable for their expertise in blending traditional and modern nutrient sources, and their influence is further highlighted by dominant players like Fonterra Co-operative Group Limited, Givaudan, and Glanbia PLC. Other industry stalwarts such as Indena S.p.A., Ingredion Incorporated, and Kemin Industries, Inc. have showcased a remarkable ability to innovate amidst evolving consumer trends.

Furthermore, companies like Kerry Group PLC, Koninklijke DSM N.V., Lonza Group, and Nestle S.A. continue to expand their research horizons, integrating cross-disciplinary practices for product improvement. The competitive landscape is also enriched by the innovative pursuits of Nexira SAS, Parchem Fine & Specialty Chemicals, Inc., Pfizer Inc., Prinova Group LLC, Roquette Freres, Sabinsa Corporation, Seppic S.A., and Tate & Lyle PLC. Their collective contributions not only elevate industry standards but also highlight the collaborative spirit prevalent among global players who are setting new benchmarks in nutraceutical ingredient research and development.

The report delves into recent significant developments in the Nutraceutical Ingredients Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., Amway Corporation, Archer-Daniels-Midland Company, Arla Foods amba, Balchem Corporation, BASF SE, Bioriginal Food & Science Corp, Cargill, Incorporated, Danone S.A., DuPont de Nemours, Inc., Fonterra Co-operative Group Limited, Givaudan, Glanbia PLC, Indena S.p.A., Ingredion Incorporated, Kemin Industries, Inc., Kerry Group PLC, Koninklijke DSM N.V., Lonza Group, Nestle S.A., Nexira SAS, Parchem Fine & Specialty Chemicals, Inc., Pfizer Inc., Prinova Group LLC, Roquette Freres, Sabinsa Corporation, Seppic S.A., and Tate & Lyle PLC. Actionable Recommendations for Industry Leaders

For industry leaders aiming to secure a competitive edge in the nutraceutical ingredients market, several actionable strategies emerge from the current trends and insights. Firstly, investing robustly in research and development is essential. By focusing on both innovation in ingredient extraction processes and identifying unique bioactive compounds, companies can differentiate their product portfolios. Prioritizing sustainability in sourcing practices, whether through plant-based, synthetic, or ethically derived animal-based ingredients, is becoming increasingly important to meet consumer expectations for transparency and environmental responsibility.

Leveraging advanced analytics to better understand consumer behavior and segmentation is another critical step. Companies should harness data-driven insights to create targeted offerings, catering to diverse consumer segments such as adults, geriatric populations, and pediatrics. Streamlining distribution channels, with a balanced focus on both offline and online platforms, will ensure broader market penetration and improved accessibility for consumers. Moreover, collaborative partnerships between research institutions and commercial entities can accelerate product innovation and enhance credibility.

Investment in digital transformation is crucial. Employing state-of-the-art digital tools for market research, consumer engagement, and supply chain management can streamline operations and foster a culture of continuous improvement. Additionally, companies should consider expanding their regional presence by tailoring their offerings to suit local consumer preferences, regulatory environments, and cultural nuances. The integration of these strategies will not only drive growth but also position industry leaders at the forefront of a rapidly transforming nutraceutical landscape.

Conclusion: Embracing the Future of Nutraceutical Ingredients

In summary, the nutraceutical ingredients market stands at a pivotal moment, characterized by rapid innovation, complex segmentation dynamics, and an expanding global footprint. With transformative shifts in technology, regulatory frameworks, and consumer behavior, the sector is poised for significant long-term growth. A strategic focus on research, innovation, and sustainability, complemented by actionable insights derived from meticulous market segmentation and regional analysis, equips industry players to navigate emerging challenges and seize valuable opportunities. The competitive landscape is dynamic, with leading companies setting benchmarks in quality and innovation, thereby paving the way for a future defined by improved wellness and enhanced product efficacy.

The integration of modern science with traditional wellness paradigms is not merely a passing trend but a robust indicator of the future direction of the industry. It is now imperative for stakeholders to adopt a forward-thinking approach, ensuring that their product lines and strategic initiatives are aligned with evolving market demands and technological advancements.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Exploring the underlying forces that are accelerating the nutraceutical ingredients market growth
    • 5.1.1.2. Crucial aspects playing a significant role in the rise of nutraceutical ingredients across sectors
    • 5.1.1.3. Insight into the primary drivers that are bolstering the nutraceutical industry's expansion wave
  • 5.1.2. Restraints
    • 5.1.2.1. Thorough examination of the deterrents influencing the nutraceutical ingredients market dynamics
    • 5.1.2.2. Comprehensive analysis of challenges hindering the growth of the nutraceutical ingredients market
    • 5.1.2.3. Identifying pivotal hurdles confronting the nutraceutical ingredients market evolution
  • 5.1.3. Opportunities
    • 5.1.3.1. Opportunities in elder-specific nutraceuticals as the aging population seeks targeted health benefits
    • 5.1.3.2. Increasing popularity of personalized nutrition boosting demand for tailored nutraceutical formulations
    • 5.1.3.3. Growing demand for plant-based nutraceuticals as consumers shift toward sustainable lifestyles
  • 5.1.4. Challenges
    • 5.1.4.1. Managing raw material shortages and price volatility affecting production costs and profitability
    • 5.1.4.2. Ensuring consistent quality and traceability across the complex nutraceutical ingredient supply chain
    • 5.1.4.3. Grappling with the varying and often conflicting research findings on ingredient effectiveness and safety
• 5.2. Market Segmentation Analysis
  • 5.2.1. Form: Demand for dry form nutraceutical ingredients due to longer shelf life
  • 5.2.2. Application: Employment across dietary supplements for development of personalized nutrition
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Nutraceutical Ingredients Market, by Type

• 6.1. Introduction
• 6.2. Amino Acids
  • 6.2.1. Essential
  • 6.2.2. Non-essential
• 6.3. Fibers
  • 6.3.1. Insoluble
  • 6.3.2. Soluble
• 6.4. Herbal Extracts
  • 6.4.1. Echinacea
  • 6.4.2. Ginseng
  • 6.4.3. Green Tea
• 6.5. Mineral
  • 6.5.1. Calcium
  • 6.5.2. Iron
  • 6.5.3. Magnesium
  • 6.5.4. Zinc
• 6.6. Probiotics
  • 6.6.1. Bifidobacteria
  • 6.6.2. Lactobacilli
  • 6.6.3. Streptococcus
  • 6.6.4. Yeast-Based
• 6.7. Vitamin
  • 6.7.1. Vitamin A
  • 6.7.2. Vitamin B
  • 6.7.3. Vitamin C
  • 6.7.4. Vitamin D

7. Nutraceutical Ingredients Market, by Form

• 7.1. Introduction
• 7.2. Capsule
• 7.3. Liquid
• 7.4. Powder
• 7.5. Tablet

8. Nutraceutical Ingredients Market, by Source

• 8.1. Introduction
• 8.2. Animal-Based
  • 8.2.1. Bovine
  • 8.2.2. Whey
• 8.3. Plant-Based
  • 8.3.1. Pea
  • 8.3.2. Rice
  • 8.3.3. Soy
• 8.4. Synthetic

9. Nutraceutical Ingredients Market, by Health Benefits

• 9.1. Introduction
• 9.2. Bone & Joint Health
• 9.3. Cognitive Health
• 9.4. Digestive Health
• 9.5. Heart Health
  • 9.5.1. Blood Pressure Regulation
  • 9.5.2. Cholesterol Management
• 9.6. Weight Management

10. Nutraceutical Ingredients Market, by Application

• 10.1. Introduction
• 10.2. Dietary Supplements
• 10.3. Functional Beverages
• 10.4. Functional Food
• 10.5. Personal Care

11. Nutraceutical Ingredients Market, by Distribution Channel

• 11.1. Introduction
• 11.2. Offline
• 11.3. Online

12. Nutraceutical Ingredients Market, by End User

• 12.1. Introduction
• 12.2. Adults
• 12.3. Geriatric
• 12.4. Pediatric

13. Americas Nutraceutical Ingredients Market

• 13.1. Introduction
• 13.2. Argentina
• 13.3. Brazil
• 13.4. Canada
• 13.5. Mexico
• 13.6. United States

14. Asia-Pacific Nutraceutical Ingredients Market

• 14.1. Introduction
• 14.2. Australia
• 14.3. China
• 14.4. India
• 14.5. Indonesia
• 14.6. Japan
• 14.7. Malaysia
• 14.8. Philippines
• 14.9. Singapore
• 14.10. South Korea
• 14.11. Taiwan
• 14.12. Thailand
• 14.13. Vietnam

15. Europe, Middle East & Africa Nutraceutical Ingredients Market

• 15.1. Introduction
• 15.2. Denmark
• 15.3. Egypt
• 15.4. Finland
• 15.5. France
• 15.6. Germany
• 15.7. Israel
• 15.8. Italy
• 15.9. Netherlands
• 15.10. Nigeria
• 15.11. Norway
• 15.12. Poland
• 15.13. Qatar
• 15.14. Russia
• 15.15. Saudi Arabia
• 15.16. South Africa
• 15.17. Spain
• 15.18. Sweden
• 15.19. Switzerland
• 15.20. Turkey
• 15.21. United Arab Emirates
• 15.22. United Kingdom

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Scenario Analysis
  • 16.3.1. CoreFX Ingredients acquires Connoils to drive innovation and customer-centric growth in the nutraceutical ingredients market
  • 16.3.2. Roquette Pharma Solutions introduces LYCAGEL Flex, a plant-based hydroxypropyl pea starch for efficient and stable soft gel capsules
  • 16.3.3. Roquette Launches Three Moisture-Protecting Ingredients for Nutraceuticals at CPhI Barcelona
  • 16.3.4. Lubrizol Launches Carbopol Polymers for Nutraceuticals with New EU Food Grade Approval
  • 16.3.5. Sabinsa Opens New Facility for Nutraceutical and Pharmaceutical Ingredients
• 16.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Ajinomoto Co., Inc.
• 2. Amway Corporation
• 3. Archer-Daniels-Midland Company
• 4. Arla Foods amba
• 5. Balchem Corporation
• 6. BASF SE
• 7. Bioriginal Food & Science Corp
• 8. Cargill, Incorporated
• 9. Danone S.A.
• 10. DuPont de Nemours, Inc.
• 11. Fonterra Co-operative Group Limited
• 12. Givaudan
• 13. Glanbia PLC
• 14. Indena S.p.A.
• 15. Ingredion Incorporated
• 16. Kemin Industries, Inc.
• 17. Kerry Group PLC
• 18. Koninklijke DSM N.V.
• 19. Lonza Group
• 20. Nestle S.A.
• 21. Nexira SAS
• 22. Parchem Fine & Specialty Chemicals, Inc.
• 23. Pfizer Inc.
• 24. Prinova Group LLC
• 25. Roquette Freres
• 26. Sabinsa Corporation
• 27. Seppic S.A.
• 28. Tate & Lyle PLC